Skip to main content
SpringerLink
Log in

Both a Calcium Antagonist and ACE Inhibitor Reverse Hypertrophy in Hypertension But a Calcium Antagonist also Depresses Contractility

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

The aim of this study was to compare the effects of a calcium antagonist, nicardipine SR, with an angiotensin-converting enzyme (ACE) inhibitor, alacepril, on the regression of left ventricular hypertrophy (LVH) and function. Twenty patients with LVH, aged 42–73 years, were treated with nicardipine SR or alacepril. Ten patients were treated with nicardipine SR (40–80 mg) for 21 months, and the other 10 patients were treated with alacepril (25–100 mg) for 18 months. All patients underwent echocardiography to assess left ventricular structure and function before and after the treatment. After nicardipine SR or alacepril treatment, blood pressure was decreased significantly from 176.0 ± 13.9/97.0 ± 5.3 mmHg to 140.0 ± 14.0/77.4 ± 7.2 mmHg and from 168.2 ± 22.3/99.0 ± 5.5 mmHg to 138.4 ± 12.5/85.2 ± 9.7 mmHg, respectively (both p < 0.01), whereas heart rate did not change (73.8 ± 14.6 beats/min vs. 69.9 ± 13.5 beats/min and 71.6 ± 9.7 vs. 65.8 ± 8.1 beats/min, respectively). The left ventricular mass index decreased significantly from 133.2 ± 11.7 g/m2 to 114.4 ± 15.7 g/m2 with nicardipine SR and from 137.1 ± 14.8 g/m2 to 99.3 ± 23.0 g/m2 with alacepril (both p < 0.01). The fractional shortening, peak shortening rate, and peak lengthening rate all improved significantly after each treatment. The end-systolic wall stress/left ventricular end-systolic volume index, as an index of left ventricular contractility, was decreased significantly after treatment with nicardipine SR but was not changed after treatment with alacepril. In conclusion, both nicardipine SR and alacepril similarly reduced LVH and improved left ventricular systolic and diastolic function. However, alacepril did not alter left ventricular contractility, whereas nicardi-pine SR decreased left ventricular contractility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Strauer BE. Structural and functional adaptation of the chronically overloaded heart in arterial hypertension. Am Heart J 1987;114:948-957.

    Google Scholar 

  2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989;110:101-107.

    Google Scholar 

  3. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990;65:441-445.

    Google Scholar 

  4. Hachamovitch R, Sonnenblick EH, Strom JA, Frishman WH. Left ventricular hypertrophy in hypertension and the effects of antihypertensive drug therapy. Curr Probl Cardiol 1988;13:371-421.

    Google Scholar 

  5. Eselin JA, Carter BL. Hypertension and left ventricular hypertrophy: Is drug therapy beneficial? Pharmacotherapy 1994;14:60-88.

    Google Scholar 

  6. Bellet M, Pagny J-Y, Chatellier G, Corvol P, Menard J. Evaluation of slow release nicardipine in essential hypertension by casual and ambulatory blood pressure measurements. Effects of acute versus chronic administration. J Hypertens 1987;5:599-604.

    Google Scholar 

  7. Takeyama K, Minato H, Fukuya F, Kawahara S, Hosoki K, Kadokawa T. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Arzneimittel forschung 1985;35(II):1502-1507.

    Google Scholar 

  8. Lin M, Sumimoto T, Hiwada K. Left ventricular geometry and cardiac function in mild to moderate essential hypertension. Hypertens Res 1995;18:151-158.

    Google Scholar 

  9. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977;55:613-618.

    Google Scholar 

  10. Wilson JR, Reichek N, Hirshfeld J, Keller CA. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med 1980;68:664-674.

    Google Scholar 

  11. Carabello BA, Spann JF. Clinical assessment of left ventricular function: Recent advances in the use of end-systolic indexes. Cardiovasc Rev Rep 1985;6:1190-1205.

    Google Scholar 

  12. Teichholtz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11.

    Google Scholar 

  13. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.

    Google Scholar 

  14. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.

    Google Scholar 

  15. Sheiban I, Arcaro G, Covi G, Accardi R, Zenorini C, Lechi A. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. J Cardiovasc Pharmacol 1987;10(Suppl 10):S187-S191.

    Google Scholar 

  16. Wang LS, Bai MY. Comparison of the effects of nitrendipine and captopril on the regression of hypertensive left ventricular hypertrophy. Chin Med J 1991;104:645-648.

    Google Scholar 

  17. Schulte K-L, Meyer-Sabellek W, Liederwald K, van Gemmeren D, Lenz T, Gotzen R. Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine. Am J Cardiol 1992;70:468-473.

    Google Scholar 

  18. Grodzicki T, Messerli FH, Soria F, Aristizabal D, Frohlich ED. Determinants of left ventricular mass reduction in essential hypertension. J Hypertens 1993;11(Suppl 5):S364-S365.

    Google Scholar 

  19. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche J-L. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.

    Google Scholar 

  20. Grossman E, Oren S, Garavaglia GE, Messerli FH, Frohlich ED. Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension. Circulation 1988;78:1394-1400.

    Google Scholar 

  21. de Simone G, Costantino G, Soro S, Lorenzo LD, Moccia D, Buonissimo S, Ferrara LA. Effects of nicardipine on left ventricular hemodynamic patterns in systemic hypertension. Am J Hypertens 1989;2:139-145.

    Google Scholar 

  22. Bignotti M, Gaudio G, Gorini G, Rinaldi O, Grandi AM, Venco A. Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension. Am J Cardiol 1993;72:1301-1304.

    Google Scholar 

  23. Muiesan ML, Agabiti-Rosei E, Romanelli G, Castellano M, Beschi M, Muiesan G. Beneficial effects of one year's treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophy. Am J Med 1988;84(Suppl 3A):129-132.

    Google Scholar 

  24. Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989;63:1093-1097.

    Google Scholar 

  25. Dahlof B, Hansson L. Regression of left ventricular hypertrophy in previously untreated essential hypertension: Different effects of enalapril and hydrochlorothiazide. J Hypertens 1992;10:1513-1524.

    Google Scholar 

  26. Habib GB, Mann DL, Zoghbi WA. Normalization of cardiac structure and function after regression of cardiac hypertrophy. Am Heart J 1994;128:333-343.

    Google Scholar 

  27. Fouad-Tarazi FM, Liebson PR. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension 1987;9(Suppl II):II65-II68.

    Google Scholar 

  28. Cerasola G, Cottone S, Nardi E, Fulantelli MA, Carone MB, D'Ignoto G. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients. J Hum Hypertens 1990;4:703-708.

    Google Scholar 

  29. Packer M. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 1989;80(Suppl IV):IV59-IV67.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Department of Internal Medicine, Ehime University, School of Medicine, Ehime, Japan

    Takumi Sumimoto & Kunio Hiwada

  2. Takanoko Hospital, Matsuyama, Ehime, Japan

    Takaaki Ochi

  3. Ehime Prefectural Imabari Hospital, Imabari, Ehime, Japan

    Taketoshi Ito

  4. Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan

    Tadafumi Joh

  5. Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan

    Shinjiro Muneta

Authors
  1. Takumi Sumimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takaaki Ochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taketoshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tadafumi Joh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shinjiro Muneta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kunio Hiwada
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sumimoto, T., Ochi, T., Ito, T. et al. Both a Calcium Antagonist and ACE Inhibitor Reverse Hypertrophy in Hypertension But a Calcium Antagonist also Depresses Contractility. Cardiovasc Drugs Ther 11, 27–32 (1997). https://doi.org/10.1023/A:1007739504829

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007739504829

Search

Navigation